Dr. Maiko Katadae joined UTEC in 2005. She focuses on seed/early stage biotech, healthcare service and medical devices. Her career in scientific research started off at the University of Tokyo. With her knowledge and experience in scientific research, she has been engaging in the process, up until the investment, in a variety of technology-edged companies of her choice. She currently sits on the board of Cyfuse, Inc (regenerative medicine), and CREWT Medical Systems (medical devices). Her past investments include PeptiDream, Inc (Biotech) (TSE 4587). She received a Ph.D. in science from the University of Tokyo.